{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:06:22Z","timestamp":1790262382809,"version":"4.1.0"},"reference-count":60,"publisher":"Portland Press Ltd.","issue":"3","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,6,19]]},"abstract":"<jats:p>Chronic fatigue syndrome (CFS), commonly known as myalgic encephalomyelitis (ME), is a debilitating disease of unknown etiology. CFS\/ME is a heterogeneous disease associated with a myriad of symptoms but with severe, prolonged fatigue as the core symptom associated with the disease. There are currently no known biomarkers for the disease, largely due to the lack of knowledge surrounding the eitopathogenesis of CFS\/ME. Numerous studies have been conducted in an attempt to identify potential biomarkers for the disease. This mini-review offers a brief summary of current research into the identification of metabolic abnormalities in CFS\/ME which may represent potential biomarkers for the disease. The progress of research into key areas including immune dysregulation, mitochondrial dysfunction, 5\u2032-adenosine monophosphate-activated protein kinase activation, skeletal muscle cell acidosis, and metabolomics are presented here. Studies outlined in this mini-review show many potential causes for the pathogenesis of CFS\/ME and identify many potential metabolic biomarkers for the disease from the aforementioned research areas. The future of CFS\/ME research should focus on building on the potential biomarkers for the disease using multi-disciplinary techniques at multiple research sites in order to produce robust data sets. Whether the metabolic changes identified in this mini-review occur as a cause or a consequence of the disease must also be established.<\/jats:p>","DOI":"10.1042\/bst20170503","type":"journal-article","created":{"date-parts":[[2018,4,17]],"date-time":"2018-04-17T10:15:19Z","timestamp":1523960119000},"page":"547-553","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Metabolic abnormalities in chronic fatigue syndrome\/myalgic encephalomyelitis: a mini-review"],"prefix":"10.1042","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6471-6281","authenticated-orcid":false,"given":"Cara","family":"Tomas","sequence":"first","affiliation":[{"name":"Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Newton","sequence":"additional","affiliation":[{"name":"Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, U.K."},{"name":"Newcastle upon Tyne Hospitals, NHS Foundation Trust, Newcastle upon Tyne, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2018,4,17]]},"reference":[{"key":"2021111818074808800_BST-2017-0503CC1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0022-3999(02)00515-9","article-title":"A systematic review and critical evaluation of the immunology of chronic fatigue syndrome","volume":"55","author":"Lyall","year":"2003","journal-title":"J. Psychosom. Res."},{"key":"2021111818074808800_BST-2017-0503CC2","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.mehy.2012.07.034","article-title":"Increased nuclear factor-\u03baB and loss of p53 are key mechanisms in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS)","volume":"79","author":"Morris","year":"2012","journal-title":"Med. Hypotheses"},{"key":"2021111818074808800_BST-2017-0503CC3","doi-asserted-by":"publisher","first-page":"E7150","DOI":"10.1073\/pnas.1710519114","article-title":"Cytokine signature associated with disease severity in chronic fatigue syndrome patients","volume":"114","author":"Montoya","year":"2017","journal-title":"Proc. Natl Acad. Sci. U.S.A."},{"key":"2021111818074808800_BST-2017-0503CC4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jcv.2006.08.013","article-title":"Chronic fatigue syndrome","volume":"37","author":"Devanur","year":"2006","journal-title":"J. Clin. Virol."},{"key":"2021111818074808800_BST-2017-0503CC5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/1479-5876-7-96","article-title":"Plasma cytokines in women with chronic fatigue syndrome","volume":"7","author":"Fletcher","year":"2009","journal-title":"J. Transl. Med."},{"key":"2021111818074808800_BST-2017-0503CC6","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s12967-017-1371-9","article-title":"Cytokine signatures in chronic fatigue syndrome patients: a case control study and the effect of anakinra treatment","volume":"15","author":"Roerink","year":"2017","journal-title":"J. Transl. Med."},{"key":"2021111818074808800_BST-2017-0503CC7","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/cei.13023","article-title":"Cytokine responses to exercise and activity in patients with chronic fatigue syndrome: case-control study","volume":"190","author":"Clark","year":"2017","journal-title":"Clin. Exp. Immunol."},{"key":"2021111818074808800_BST-2017-0503CC8","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1038\/s41598-018-20941-w","article-title":"Value of circulating cytokine profiling during submaximal exercise testing in myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"8","author":"Moneghetti","year":"2018","journal-title":"Sci. Rep."},{"issue":"Suppl 1","key":"2021111818074808800_BST-2017-0503CC9","doi-asserted-by":"crossref","first-page":"S136","DOI":"10.1093\/clinids\/18.Supplement_1.S136","article-title":"Immunologic abnormalities associated with chronic fatigue syndrome","volume":"18","author":"Barker","year":"1994","journal-title":"Clin. Infect. Dis."},{"key":"2021111818074808800_BST-2017-0503CC10","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.autrev.2008.08.003","article-title":"Immunological aspects of chronic fatigue syndrome","volume":"8","author":"Lorusso","year":"2009","journal-title":"Autoimmun. Rev."},{"key":"2021111818074808800_BST-2017-0503CC11","doi-asserted-by":"publisher","first-page":"3600","DOI":"10.4049\/jimmunol.169.7.3600","article-title":"IL-21 up-regulates the expression of genes associated with innate immunity and Th1 response","volume":"169","author":"Strengell","year":"2002","journal-title":"J. Immunol."},{"key":"2021111818074808800_BST-2017-0503CC12","first-page":"745","article-title":"In chronic fatigue syndrome, the decreased levels of omega-3 poly-unsaturated fatty acids are related to lowered serum zinc and defects in T cell activation","volume":"26","author":"Maes","year":"2005","journal-title":"Neuroendocrinol. Lett."},{"key":"2021111818074808800_BST-2017-0503CC13","first-page":"477","article-title":"Decreased expression of CD69 in chronic fatigue syndrome in relation to inflammatory markers: evidence for a severe disorder in the early activation of T lymphocytes and natural killer cells","volume":"28","author":"Mihaylova","year":"2007","journal-title":"Neuroendocrinol. Lett."},{"key":"2021111818074808800_BST-2017-0503CC14","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1136\/jcp.2006.042408","article-title":"Myalgic encephalomyelitis: a review with emphasis on key findings in biomedical research","volume":"60","author":"Hooper","year":"2007","journal-title":"J. Clin. Pathol."},{"key":"2021111818074808800_BST-2017-0503CC15","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/j.1365-3083.1994.tb03511.x","article-title":"Immunological abnormalities in patients with chronic fatigue syndrome","volume":"40","author":"Tirelli","year":"1994","journal-title":"Scand. J. Immunol."},{"key":"2021111818074808800_BST-2017-0503CC16","doi-asserted-by":"publisher","first-page":"e10817","DOI":"10.1371\/journal.pone.0010817","article-title":"Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV\/CD26","volume":"5","author":"Fletcher","year":"2010","journal-title":"PLoS ONE"},{"key":"2021111818074808800_BST-2017-0503CC17","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1128\/jcm.28.6.1403-1410.1990","article-title":"Immunologic abnormalities in chronic fatigue syndrome","volume":"28","author":"Klimas","year":"1990","journal-title":"J. Clin. Microbiol."},{"key":"2021111818074808800_BST-2017-0503CC18","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1136\/bmj.38933.585764.AE","article-title":"Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study","volume":"333","author":"Hickie","year":"2006","journal-title":"Br. Med. J."},{"key":"2021111818074808800_BST-2017-0503CC19","doi-asserted-by":"publisher","first-page":"e26358","DOI":"10.1371\/journal.pone.0026358","article-title":"Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study","volume":"6","author":"Fluge","year":"2011","journal-title":"PLoS ONE"},{"key":"2021111818074808800_BST-2017-0503CC20","doi-asserted-by":"publisher","first-page":"e0129898","DOI":"10.1371\/journal.pone.0129898","article-title":"B-lymphocyte depletion in myalgic encephalopathy\/chronic fatigue syndrome. An open-label phase II study with rituximab maintenance treatment","volume":"10","author":"Fluge","year":"2015","journal-title":"PLoS ONE"},{"key":"2021111818074808800_BST-2017-0503CC21","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1172\/JCI118990","article-title":"Autoantibodies to nuclear envelope antigens in chronic fatigue syndrome","volume":"98","author":"Konstantinov","year":"1996","journal-title":"J. Clin. Investig."},{"key":"2021111818074808800_BST-2017-0503CC22","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s11011-012-9316-8","article-title":"IgM-mediated autoimmune responses directed against anchorage epitopes are greater in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS) than in major depression","volume":"27","author":"Maes","year":"2012","journal-title":"Metab. Brain Dis."},{"key":"2021111818074808800_BST-2017-0503CC23","first-page":"225","article-title":"Autoantibodies against muscarinic cholinergic receptor in chronic fatigue syndrome","volume":"12","author":"Tanaka","year":"2003","journal-title":"Int. J. Mol. Med."},{"key":"2021111818074808800_BST-2017-0503CC24","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/art.1780400215","article-title":"High frequency of autoantibodies to insoluble cellular antigens in patients with chronic fatigue syndrome","volume":"40","author":"Von Mikecz","year":"1997","journal-title":"Arthritis Rheum."},{"key":"2021111818074808800_BST-2017-0503CC25","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.bbi.2015.09.013","article-title":"Antibodies to \u03b2 adrenergic and muscarinic cholinergic receptors in patients with chronic fatigue syndrome","volume":"52","author":"Loebel","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"2021111818074808800_BST-2017-0503CC26","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/cei.12043","article-title":"Altered functional B cell subset populations in patients with chronic fatigue syndrome compared to healthy controls","volume":"172","author":"Bradley","year":"2013","journal-title":"Clin. Exp. Immunol."},{"key":"2021111818074808800_BST-2017-0503CC27","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/intimm\/dxt068","article-title":"Role of adaptive and innate immune cells in chronic fatigue syndrome\/myalgic encephalomyelitis","volume":"26","author":"Brenu","year":"2014","journal-title":"Int. Immunol."},{"key":"2021111818074808800_BST-2017-0503CC28","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.jad.2011.09.004","article-title":"Evidence for inflammation and activation of cell-mediated immunity in myalgic Encephalomyelitis\/chronic fatigue syndrome (ME\/CFS): increased interleukin-1, tumor necrosis factor-\u03b1, PMN-elastase, lysozyme and neopterin","volume":"136","author":"Maes","year":"2012","journal-title":"J. Affect. Disord."},{"issue":"Suppl 1","key":"2021111818074808800_BST-2017-0503CC29","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1093\/clinids\/18.Supplement_1.S117","article-title":"Part III: viral studies of chronic fatigue syndrome","volume":"18","author":"Levy","year":"1994","journal-title":"Clin. Infect. Dis."},{"key":"2021111818074808800_BST-2017-0503CC30","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bbi.2011.06.016","article-title":"Chronic fatigue syndrome, the immune system and viral infection","volume":"26","author":"Bansal","year":"2012","journal-title":"Brain Behav. Immun."},{"key":"2021111818074808800_BST-2017-0503CC31","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.bbacli.2014.04.001","article-title":"Association of mitochondrial dysfunction and fatigue: a review of the literature","volume":"1","author":"Filler","year":"2014","journal-title":"BBA Clin."},{"key":"2021111818074808800_BST-2017-0503CC32","first-page":"1","article-title":"Chronic fatigue syndrome and mitochondrial dysfunction","volume":"2","author":"Myhill","year":"2009","journal-title":"Int. J. Clin. Exp. Med."},{"key":"2021111818074808800_BST-2017-0503CC33","first-page":"208","article-title":"Mitochondrial dysfunction and the pathophysiology of myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS)","volume":"5","author":"Booth","year":"2012","journal-title":"Int. J. Clin. Exp. Med."},{"key":"2021111818074808800_BST-2017-0503CC34","first-page":"1","article-title":"Targeting mitochondrial dysfunction in the treatment of myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS)\u2014a clinical audit","volume":"6","author":"Myhill","year":"2013","journal-title":"Int. J. Clin. Exp. Med."},{"key":"2021111818074808800_BST-2017-0503CC35","doi-asserted-by":"publisher","first-page":"e89376","DOI":"10.1172\/jci.insight.89376","article-title":"Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy\/chronic fatigue syndrome","volume":"1","author":"Fluge","year":"2016","journal-title":"JCI Insight."},{"key":"2021111818074808800_BST-2017-0503CC36","first-page":"e221","article-title":"Elevated energy production in chronic fatigue syndrome patients","volume":"2","author":"Lawson","year":"2016","journal-title":"J. Nat. Sci."},{"key":"2021111818074808800_BST-2017-0503CC37","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s10974-008-9128-y","article-title":"Specific correlations between muscle oxidative stress and chronic fatigue syndrome: a working hypothesis","volume":"28","author":"Fulle","year":"2007","journal-title":"J. Muscle Res. Cell Motil."},{"key":"2021111818074808800_BST-2017-0503CC38","doi-asserted-by":"publisher","first-page":"e0186802","DOI":"10.1371\/journal.pone.0186802","article-title":"Cellular bioenergetics is impaired in patients with chronic fatigue syndrome","volume":"12","author":"Tomas","year":"2017","journal-title":"PLoS ONE"},{"key":"2021111818074808800_BST-2017-0503CC39","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/1479-5876-8-93","article-title":"Patients with chronic fatigue syndrome performed worse than controls in a controlled repeated exercise study despite a normal oxidative phosphorylation capacity","volume":"8","author":"Vermeulen","year":"2010","journal-title":"J. Transl. Med."},{"key":"2021111818074808800_BST-2017-0503CC40","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1136\/jnnp.74.10.1382","article-title":"Enterovirus related metabolic myopathy: a postviral fatigue syndrome","volume":"74","author":"Lane","year":"2003","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"2021111818074808800_BST-2017-0503CC41","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/S0960-8966(98)00021-2","article-title":"Heterogeneity in chronic fatigue syndrome: evidence from magnetic resonance spectroscopy of muscle","volume":"8","author":"Lane","year":"1998","journal-title":"Neuromuscul. Disord."},{"key":"2021111818074808800_BST-2017-0503CC42","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1042\/CS20020279","article-title":"Blood flow and muscle metabolism in chronic fatigue syndrome","volume":"104","author":"McCully","year":"2003","journal-title":"Clin. Sci."},{"key":"2021111818074808800_BST-2017-0503CC43","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.mito.2011.05.005","article-title":"Mitochondrial enzymes discriminate between mitochondrial disorders and chronic fatigue syndrome","volume":"11","author":"Smits","year":"2011","journal-title":"Mitochondrion"},{"key":"2021111818074808800_BST-2017-0503CC44","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1136\/jnnp.56.6.679","article-title":"Skeletal muscle bioenergetics in the chronic fatigue syndrome","volume":"56","author":"Barnes","year":"1993","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"2021111818074808800_BST-2017-0503CC45","doi-asserted-by":"crossref","unstructured":"Rutherford, G.\n           (2016) Investigating the biochemical basis of muscle cell dysfunction in chronic fatigue syndrome (Chapter 4). Ph.D. Thesis, Newcastle University","DOI":"10.1155\/2016\/2497348"},{"key":"2021111818074808800_BST-2017-0503CC46","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/S0891-5849(00)00419-6","article-title":"Specific oxidative alterations in vastus lateralis muscle of patients with the diagnosis of chronic fatigue syndrome","volume":"29","author":"Fulle","year":"2000","journal-title":"Free Radic. Biol. Med."},{"key":"2021111818074808800_BST-2017-0503CC47","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1365-2796.2005.01452.x","article-title":"Chronic fatigue syndrome: assessment of increased oxidative stress and altered muscle excitability in response to incremental exercise","volume":"257","author":"Jammes","year":"2005","journal-title":"J. Int. Med."},{"key":"2021111818074808800_BST-2017-0503CC48","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.mehy.2008.02.022","article-title":"Treating chronic fatigue states as a disease of the regulation of energy metabolism","volume":"71","author":"Bains","year":"2008","journal-title":"Med. Hypotheses"},{"key":"2021111818074808800_BST-2017-0503CC49","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1378\/chest.102.6.1716","article-title":"Skeletal muscle metabolism in the chronic fatigue syndrome. In vivo assessment by 31P nuclear magnetic resonance spectroscopy","volume":"102","author":"Wong","year":"1992","journal-title":"Chest"},{"key":"2021111818074808800_BST-2017-0503CC50","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/ncb2329","article-title":"The AMP-activated protein kinase (AMPK) signaling pathway coordinates cell growth, autophagy, & metabolism","volume":"13","author":"Mihaylova","year":"2012","journal-title":"Nat. Cell Biol."},{"key":"2021111818074808800_BST-2017-0503CC51","doi-asserted-by":"publisher","first-page":"e0122982","DOI":"10.1371\/journal.pone.0122982","article-title":"Abnormalities of AMPK activation and glucose uptake in cultured skeletal muscle cells from individuals with chronic fatigue syndrome","volume":"10","author":"Brown","year":"2015","journal-title":"PLoS ONE"},{"key":"2021111818074808800_BST-2017-0503CC52","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.bbadis.2015.03.005","article-title":"Metformin and caloric restriction induce an AMPK-dependent restoration of mitochondrial dysfunction in fibroblasts from fibromyalgia patients","volume":"1852","author":"Alcocer-G\u00f3mez","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"2021111818074808800_BST-2017-0503CC53","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/j.1365-2796.2009.02160.x","article-title":"Abnormalities in pH handling by peripheral muscle and potential regulation by the autonomic nervous system in chronic fatigue syndrome","volume":"267","author":"Jones","year":"2010","journal-title":"J. Intern. Med."},{"key":"2021111818074808800_BST-2017-0503CC54","first-page":"17","article-title":"Muscle fatigue: lactic acid or inorganic phosphate the major cause?","volume":"17","author":"Westerblad","year":"2006","journal-title":"News Physiol. Sci."},{"key":"2021111818074808800_BST-2017-0503CC55","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1242\/jeb.131.1.69","article-title":"Contributions of anaerobic metabolism to pH regulation in animal tissues: theory","volume":"131","author":"P\u00f6rtner,","year":"1987","journal-title":"J. Exp. Biol."},{"key":"2021111818074808800_BST-2017-0503CC56","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1152\/ajpregu.00114.2004","article-title":"Biochemistry of exercise-induced metabolic acidosis","volume":"287","author":"Robergs","year":"2004","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"2021111818074808800_BST-2017-0503CC57","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1172\/JCI113730","article-title":"Sympathetic nerve discharge is coupled to muscle cell pH during exercise in humans","volume":"82","author":"Victor","year":"1988","journal-title":"J. Clin. Investig."},{"key":"2021111818074808800_BST-2017-0503CC58","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1002\/nbm.2772","article-title":"Increased ventricular lactate in chronic fatigue syndrome. III. Relationships to cortical glutathione and clinical symptoms implicate oxidative stress in disorder pathophysiology","volume":"25","author":"Shungu","year":"2012","journal-title":"NMR Biomed."},{"key":"2021111818074808800_BST-2017-0503CC59","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/00005768-200201000-00009","article-title":"Maximal oxygen uptake and lactate metabolism are normal in chronic fatigue syndrome","volume":"34","author":"Sargent","year":"2002","journal-title":"Med. Sci. Sports Exerc."},{"key":"2021111818074808800_BST-2017-0503CC60","doi-asserted-by":"publisher","first-page":"E5472","DOI":"10.1073\/pnas.1607571113","article-title":"Metabolic features of chronic fatigue syndrome","volume":"113","author":"Naviaux","year":"2016","journal-title":"Proc. Natl Acad. Sci. U.S.A."}],"container-title":["Biochemical Society Transactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/biochemsoctrans\/article-pdf\/46\/3\/547\/479585\/bst-2017-0503c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/biochemsoctrans\/article-pdf\/46\/3\/547\/479585\/bst-2017-0503c.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T18:28:23Z","timestamp":1637260103000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/biochemsoctrans\/article\/46\/3\/547\/67402\/Metabolic-abnormalities-in-chronic-fatigue"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,17]]},"references-count":60,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,4,17]]},"published-print":{"date-parts":[[2018,6,19]]}},"URL":"https:\/\/doi.org\/10.1042\/bst20170503","relation":{},"ISSN":["0300-5127","1470-8752"],"issn-type":[{"value":"0300-5127","type":"print"},{"value":"1470-8752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,17]]}}}